Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluconazole for cutaneous leishmaniasis caused by Leishmania (Viannia) guyanensis in Manaus
RBR-8w292wPhase 2Completed
- Sponsor
- Fundação de Medicina Tropical Doutor Heitor Vieira Dourado
- Start
- Mar 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of fluconazole in cutaneous leishmaniasis (CL) and leishmaniasis (2 cohorts), sponsored by Fundação de Medicina Tropical Doutor Heitor Vieira Dourado. Started Mar 2014; status: completed.
02
Drugs
fluconazole
03
Conditions
cutaneous leishmaniasis (CL)leishmaniasis
Beyond the preview
Go deeper on RBR-8w292w.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-8w292w.